Maternal Biomarker Index (BNP-based) Calculator

Clinical calculation support · Verify results before clinical use

Calculator inputs

Enter the available measurements to calculate the legacy arithmetic index. This index has not been validated for clinical risk prediction.

Enter BNP, not NT-proBNP. The two assays are not interchangeable.
Enter gestational age in weeks; decimals may be used if known.
Reset

Clinical context and limitations

BNP is a marker of myocardial wall stress and can support the assessment of suspected heart failure in pregnancy. It is not, by itself, a stand-alone prediction model for all maternal complications.

How to interpret BNP in pregnancy

  • Natriuretic peptide results should be interpreted with symptoms, examination, cardiac history, echocardiography, and the clinical context.
  • Low BNP/NT-proBNP concentrations can have useful negative predictive value for heart failure, while an elevated result requires clinical evaluation and does not automatically establish heart failure.
  • BNP and NT-proBNP are different analytes and their numerical values and thresholds should not be substituted for one another.

Important model limitation

The original file proposes the equation Index = (0.05 × age) + (0.1 × BNP) + (0.02 × gestational week) and thresholds of <10, 10–<20, and ≥20. The cited publication and these coefficients/thresholds could not be independently verified in the available source checks. Therefore, this page retains the arithmetic output for transparency but deliberately does not present those thresholds as clinical risk categories.

Evidence and references

2025 ESC Guidelines for the management of cardiovascular disease and pregnancy. European Society of Cardiology. The guideline discusses natriuretic peptides in pregnancy and their role in the evaluation of heart failure and women with pre-existing cardiovascular disease. Official ESC guideline page
The Utilization and Interpretation of Cardiac Biomarkers During Pregnancy: JACC: Advances Expert Panel. JACC: Advances. 2022. doi:10.1016/j.jacadv.2022.100064. Reviews the interpretation and clinical use of cardiac biomarkers during pregnancy. https://doi.org/10.1016/j.jacadv.2022.100064
Original MBI citation supplied in the source file — not verified. Taniuchi S, et al. “Maternal Biomarker Index using B-type Natriuretic Peptide for Prediction of Maternal Complications.” J Obstet Gynaecol Res. 2016;42(5):560–567. doi:10.1111/jog.12918. The citation, formula, and thresholds should be checked against the original publication before clinical use.
Clinical disclaimer: This page is an educational calculator interface, not a validated maternal risk score. The displayed legacy index must not be used to diagnose disease, estimate an individual patient's risk of maternal complications, or determine treatment or monitoring. Evaluate suspected cardiovascular disease during pregnancy using current guidance and appropriate multidisciplinary clinical assessment.